Pasqui Edoardo, de Donato Gianmarco, Molino Cecilia, Abu Leil Mustafa, Anzaldi Manfredi Giuseppe, Galzerano Giuseppe, Palasciano Giancarlo
Vascular Surgery Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy.
Biomedicines. 2023 Jul 6;11(7):1920. doi: 10.3390/biomedicines11071920.
In this study, we evaluated the role of preoperative inflammatory markers as Neutrophil-to-Lymphocyte (NLR) and Platelet-to-Lymphocyte (PLR) ratios in relation to post-endovascular aneurysm repair (EVAR) sac shrinkage, which is known to be an important factor for abdominal aortic aneurysm (AAA) healing.
This was a single-center retrospective observational study. All patients who underwent the EVAR procedure from January 2017 to December 2020 were eligible for this study. Pre-operative blood samples of all patients admitted were used to calculate NLR and PLR. Sac shrinkage was defined as a decrease of ≥5 mm in the maximal sac diameter. The optimal NLR and PLR cut-offs for aneurysmal sac shrinkage were obtained from ROC curves. Stepwise multivariate analysis was performed in order to identify independent risk and protective factors for the absence of AAA shrinkage. Kaplan-Meier curves were used to evaluate survival rates with respect to the AAA shrinkage.
A total of 184 patients were finally enrolled. The mean age was 75.8 ± 8.3 years, and 85.9% were male (158/184). At a mean follow-up of 43 ± 18 months, sac shrinkage was registered in 107 patients (58.1%). No-shrinking AAA patients were more likely to be older, to have a higher level of NLR and PLR, and be an active smoker. Kaplan-Meier curves highlighted a higher rate of survival for shrinking AAA patients with respect to their counterparts ( < 0.03). Multivariate analysis outlined active smoking and NLR as independent risk factors for no-shrinking AAA.
Inflammation emerged as a possible causative factor for no-shrinking AAA, playing a role in aneurysmal sac remodeling. This study revealed that inflammatory biomarkers, such as NLR and PLR, can be used as a preoperative index of AAA sac behavior after EVAR procedures.
在本研究中,我们评估了术前炎症标志物中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)与血管内动脉瘤修复(EVAR)术后瘤腔缩小的关系,瘤腔缩小是腹主动脉瘤(AAA)愈合的一个重要因素。
这是一项单中心回顾性观察研究。2017年1月至2020年12月期间接受EVAR手术的所有患者均符合本研究条件。所有入院患者的术前血样用于计算NLR和PLR。瘤腔缩小定义为最大瘤腔直径减少≥5mm。通过ROC曲线获得动脉瘤瘤腔缩小的最佳NLR和PLR临界值。进行逐步多变量分析以确定AAA未缩小的独立风险和保护因素。采用Kaplan-Meier曲线评估AAA缩小情况的生存率。
最终共纳入184例患者。平均年龄为75.8±8.3岁,男性占85.9%(158/184)。平均随访43±18个月时,107例患者(58.1%)出现瘤腔缩小。未缩小的AAA患者更可能年龄较大、NLR和PLR水平较高且为现吸烟者。Kaplan-Meier曲线显示,瘤腔缩小的AAA患者的生存率高于未缩小的患者(P<0.03)。多变量分析表明,现吸烟和NLR是AAA未缩小的独立危险因素。
炎症可能是AAA未缩小的一个致病因素,在动脉瘤瘤腔重塑中起作用。本研究表明,NLR和PLR等炎症生物标志物可作为EVAR术后AAA瘤腔行为的术前指标。